MENU
+Compare
ACHV
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$3.09
Change
+$0.02 (+0.65%)
Capitalization
106.26M

ACHV Achieve Life Sciences Forecast, Technical & Fundamental Analysis

a developer of specialty pharmaceuticals

Industry Biotechnology
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ACHV with price predictions
Jan 08, 2025

Momentum Indicator for ACHV turns negative, indicating new downward trend

ACHV saw its Momentum Indicator move below the 0 level on January 08, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned negative. In of the 73 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ACHV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ACHV entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ACHV's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 51 cases where ACHV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ACHV advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.386) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ACHV has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ACHV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ACHV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ACHV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ACHV is expected to report earnings to fall 5.19% to -34 cents per share on March 13

Achieve Life Sciences ACHV Stock Earnings Reports
Q4'24
Est.
$-0.34
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.01
Q1'24
Missed
by $0.03
Q4'23
Beat
by $0.05
The last earnings report on November 07 showed earnings per share of -36 cents, missing the estimate of -27 cents. With 379.92K shares outstanding, the current market capitalization sits at 106.26M.
A.I. Advisor
published General Information

General Information

a developer of specialty pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
22722 29th Dr. SE
Phone
+1 425 686-1500
Employees
22
Web
https://www.achievelifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRHKY6.290.25
+4.14%
China Resources Beer Holdings Company Limited
DHLGY36.420.67
+1.87%
Deutsche Post AG
SPI0.77N/A
N/A
SPI Energy Co Ltd
STRNY30.78-0.08
-0.28%
Severn Trent PLC
ALVOF3.66-0.03
-0.81%
Alvopetro Energy Ltd

ACHV and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ACHV has been loosely correlated with DNLI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ACHV jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACHV
1D Price
Change %
ACHV100%
+0.65%
DNLI - ACHV
37%
Loosely correlated
+1.20%
PLRX - ACHV
36%
Loosely correlated
-3.36%
ELVN - ACHV
34%
Loosely correlated
-2.36%
OLMA - ACHV
32%
Poorly correlated
+7.20%
CRNX - ACHV
32%
Poorly correlated
+2.38%
More